BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 36136435)

  • 1. Availability of Medications for Alcohol Use Disorder Treatment in Medicare Part D, 2014-2018.
    Harris SJ; Abraham AJ; Yarbrough CR
    J Stud Alcohol Drugs; 2022 Sep; 83(5):653-661. PubMed ID: 36136435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Availability of Medications for the Treatment of Alcohol Use Disorder in U.S. Counties, 2016-2019.
    Abraham AJ; Yarbrough CR
    J Stud Alcohol Drugs; 2021 Nov; 82(6):689-699. PubMed ID: 34762028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. County-level access to opioid use disorder medications in medicare Part D (2010-2015).
    Abraham AJ; Adams GB; Bradford AC; Bradford WD
    Health Serv Res; 2019 Apr; 54(2):390-398. PubMed ID: 30665272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes After Initiation of Medications for Alcohol Use Disorder at Hospital Discharge.
    Bernstein EY; Baggett TP; Trivedi S; Herzig SJ; Anderson TS
    JAMA Netw Open; 2024 Mar; 7(3):e243387. PubMed ID: 38551564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using a cascade of care framework to identify gaps in access to medications for alcohol use disorder in British Columbia, Canada.
    Socias ME; Scheuermeyer FX; Cui Z; Mok WY; Crabtree A; Fairbairn N; Nolan S; Slaunwhite A; Ti L
    Addiction; 2023 Nov; 118(11):2128-2138. PubMed ID: 37488683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spillover of Medicaid Expansion to Prescribing of Opioid Use Disorder Medications in Medicare Part D.
    Abraham AJ; Lawler EC; Harris SJ; Bagwell Adams G; Bradford WD
    Psychiatr Serv; 2022 Apr; 73(4):418-424. PubMed ID: 34407628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attitudes about medications for alcohol use disorder among individuals with serious mental illness: A health belief model analysis.
    Bromley E; Tarn DM; McCreary M; Hurley B; Ober AJ; Watkins KE
    J Subst Abuse Treat; 2020 Jul; 114():108007. PubMed ID: 32527506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication prescribing for alcohol use disorders during alcohol-related encounters in a Colorado regional healthcare system.
    Chockalingam L; Burnham EL; Jolley SE
    Alcohol Clin Exp Res; 2022 Jun; 46(6):1094-1102. PubMed ID: 35723682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medications for alcohol use disorder improve survival in patients with hazardous drinking and alcohol-associated cirrhosis.
    Rabiee A; Mahmud N; Falker C; Garcia-Tsao G; Taddei T; Kaplan DE
    Hepatol Commun; 2023 Apr; 7(4):. PubMed ID: 36972386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of initiation of and retention on medications for alcohol use disorder among people living with and without HIV.
    Oldfield BJ; McGinnis KA; Edelman EJ; Williams EC; Gordon AJ; Akgün K; Crystal S; Fiellin LE; Gaither JR; Goulet JL; Korthuis PT; Marshall BDL; Justice AC; Bryant K; Fiellin DA; Kraemer KL
    J Subst Abuse Treat; 2020 Feb; 109():14-22. PubMed ID: 31856946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addiction Consult Service and Inpatient Outcomes Among Patients with Alcohol Use Disorder.
    Singh-Tan S; Torres-Lockhart K; Jakubowski A; Lu T; Starrels J; De Lima P; Arnsten J; Nahvi S; Southern W
    J Gen Intern Med; 2023 Nov; 38(14):3216-3223. PubMed ID: 37100986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiscale dimensions of county-level disparities in opioid use disorder rates among older Medicare beneficiaries.
    Yang TC; Shoff C; Choi SE; Sun F
    Front Public Health; 2022; 10():993507. PubMed ID: 36225787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COUNTY-LEVEL ANALYSIS OF EYE EXAM ACCESS AND UTILIZATION IN THE UNITED STATES.
    Bhatnagar A; Skrehot H; Ahmed M
    Ophthalmic Epidemiol; 2024 Apr; 31(2):152-158. PubMed ID: 37227243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initiation of Medication for Alcohol Use Disorder for Inpatients with Alcohol Withdrawal Syndromes.
    Krimpuri R; Youngs C; Emerman C
    J Stud Alcohol Drugs; 2023 Mar; 84(2):293. PubMed ID: 36971765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. County and Physician Variation in Benzodiazepine Prescribing to Medicare Beneficiaries by Primary Care Physicians in the USA.
    Maust DT; Lin LA; Blow FC; Marcus SC
    J Gen Intern Med; 2018 Dec; 33(12):2180-2188. PubMed ID: 30251216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Social Vulnerability and the Prevalence of Opioid Use Disorder Among Older Medicare Beneficiaries in U.S. Counties.
    Yang TC; Kim S; Matthews SA; Shoff C
    J Gerontol B Psychol Sci Soc Sci; 2023 Dec; 78(12):2111-2121. PubMed ID: 37788567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of behavioral and medication treatment for alcohol use disorder on changes in HIV-related outcomes among patients with HIV: A longitudinal analysis.
    McGinnis KA; Skanderson M; Edelman EJ; Gordon AJ; Korthuis PT; Oldfield B; Williams EC; Wyse J; Bryant K; Fiellin DA; Justice AC; Kraemer KL
    Drug Alcohol Depend; 2020 Dec; 217():108272. PubMed ID: 32971391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in first-time treatment admissions for older adults with alcohol use disorder: Availability of medical and specialty clinical services in hospital, residential, and outpatient facilities.
    Huhn AS; Hobelmann JG; Ramirez A; Strain EC; Oyler GA
    Drug Alcohol Depend; 2019 Dec; 205():107694. PubMed ID: 31704379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescribing Medications for Alcohol Use Disorder: A Qualitative Study of Primary Care Physician Decision Making.
    Bhardwaj A; Sousa JL; Huskamp HA; Busch AB; Kennedy-Hendricks A; Hodgkin D; Horgan C; Uscher-Pines L
    Ann Fam Med; 2023; 21(4):332-337. PubMed ID: 37487716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National outpatient medication utilization for opioid and alcohol use disorders from 2014 to 2016.
    Evoy KE; Roccograndi L; Le S; Leonard CE; Covvey JR; Ochs L; Peckham AM; Soprano SE; Reveles KR
    J Subst Abuse Treat; 2020 Dec; 119():108141. PubMed ID: 33138926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.